These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2544049)

  • 1. [Interleukin-1-like factor from human B-lymphocytes transformed by the Epstein-Barr virus].
    Kotov AIu; Simbirtsev AS; Perumov ND; Ketlinskiĭ SA
    Tsitologiia; 1989 Feb; 31(2):226-33. PubMed ID: 2544049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 alpha acts as an autocrine growth factor for RPMI 1788, an Epstein-Barr virus-transformed human B cell line.
    Vandenabeele P; Jayaram B; Devos R; Shaw A; Fiers W
    Eur J Immunol; 1988 Jul; 18(7):1027-31. PubMed ID: 2841138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and biochemical characterization of a human autocrine growth factor produced by Epstein-Barr virus-transformed B cells.
    Buck J; Hämmerling U; Hoffmann MK; Levi E; Welte K
    J Immunol; 1987 May; 138(9):2923-8. PubMed ID: 3033079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
    Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
    J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of EBV transformation and cloning efficiency of human B cells using culture supernatants from lymphoblastoid cell lines.
    Mevissen ML; Kwekkeboom J; Goormachtig E; Lindhout E; de Groot C
    Hum Antibodies Hybridomas; 1993 Apr; 4(2):66-73. PubMed ID: 8390865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autocrine growth function of human interleukin 1 molecules on ROHA-9, an EBV-transformed human B cell line.
    Scala G; Morrone G; Tamburrini M; Alfinito F; Pastore CI; D'Alessio G; Venuta S
    J Immunol; 1987 Apr; 138(8):2527-34. PubMed ID: 2435800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cell-derived growth factors and cytokines on the clonal outgrowth of EBV-infected B cells and established lymphoblastoid cell lines.
    Ifversen P; Zhang XM; Ohlin M; Zeuthen J; Borrebaeck CA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):115-23. PubMed ID: 8395232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
    Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
    Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Epstein-Barr virus encoded cytokine viral interleukin-10 enhances transformation of human B lymphocytes.
    Stuart AD; Stewart JP; Arrand JR; Mackett M
    Oncogene; 1995 Nov; 11(9):1711-9. PubMed ID: 7478598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the IL-6 gene induces differentiation of a human monoclonal EBV-transformed B cell line.
    Jochems GJ; Bende RJ; Klein MR; Zeijlemaker WP; van Lier RA
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):124-33. PubMed ID: 8395233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of EBV-activated human B cells by monocytes and monocyte products. Role of IFN-beta 2/B cell stimulatory factor 2/IL-6.
    Tosato G; Gerrard TL; Goldman NG; Pike SE
    J Immunol; 1988 Jun; 140(12):4329-36. PubMed ID: 2836512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoblastoid B cell lines produce an interleukin-1-like activity that can be serologically distinct from macrophage interleukin-1.
    Valentine M; Lotz M; Dinarello CA; Carson DA; Vaughan JH
    Lymphokine Res; 1986; 5(3):173-83. PubMed ID: 3018386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NADPH oxidase activity and cytochrome b558 content of human Epstein-Barr-virus-transformed B lymphocytes correlate with expression of genes encoding components of the oxidase system.
    Condino-Neto A; Newburger PE
    Arch Biochem Biophys; 1998 Dec; 360(2):158-64. PubMed ID: 9851826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a B cell-derived growth-enhancing factor produced by a human B cell line established from a patient with rheumatoid arthritis.
    Kang H; Koyasu S; Takei M; Tomura K; Karasaki M; Yahara I; Sawada S
    J Immunol; 1987 Aug; 139(4):1154-60. PubMed ID: 3497197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transformation of rabbit lymphocytes by an Epstein-Barr virus-related herpesvirus from Macaca arctoides.
    Meerbach A; Friedrichs C; Thust R; Wutzler P
    Arch Virol; 2004 Jun; 149(6):1083-94. PubMed ID: 15168196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model of angiogenesis in mice with severe combined immunodeficiency (SCID) and xenoengrafted with Epstein-Barr virus-transformed B cells.
    Woodford NL; Call DR; Remick DG; Rochford R
    Comp Med; 2004 Apr; 54(2):209-15. PubMed ID: 15134368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.